Thu, January 18, 2024
Wed, January 17, 2024
Tue, January 16, 2024
Mon, January 15, 2024
Fri, January 12, 2024
Thu, January 11, 2024
Wed, January 10, 2024

Reni Benjamin Reiterated (BPMC) at Buy and Held Target at $114 on, Jan 16th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-114-on-jan-16th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Reni Benjamin of JMP Securities, Reiterated "Blueprint Medicines Corporation" (BPMC) at Buy and Held Target at $114 on, Jan 16th, 2024.

Reni has made no other calls on BPMC in the last 4 months.



There are 8 other peers that have a rating on BPMC. Out of the 8 peers that are also analyzing BPMC, 2 agree with Reni's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $63 on, Friday, October 27th, 2023
  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $58 on, Friday, October 27th, 2023


These are the ratings of the 6 analyists that currently disagree with Reni


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $97 on, Tuesday, January 9th, 2024
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $100 on, Friday, December 22nd, 2023
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Tuesday, December 19th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $85 on, Monday, December 11th, 2023
  • Ami Fadia of "Needham" Maintained at Strong Buy with Increased Target to $74 on, Friday, October 27th, 2023
  • Matthew Biegler of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $85 on, Friday, October 27th, 2023

Publication Contributing Sources